期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂在慢性心力衰竭治疗中的应用 被引量：8

Applications of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of chronic heart failure
下载PDF
导出
摘要 心力衰竭是多种心脏病的最终死亡原因,阻断肾素-血管紧张素-醛固酮系统(renin angiotensin aldosterone system,RAAS)是减慢心力衰竭病变进展的主要策略。血管紧张素转换酶抑制剂(angiotensin converting enzyme inhibitors,ACEI)和血管紧张素受体拮抗剂(angiotensin receptor blockers,ARB)是目前最常用的阻断RAAS的药物。本文对慢性心力衰竭评估,以及ACEI和ARB在慢性心力衰竭治疗中的应用进行综述。 Heart failure is the ultimate cause of death in a variety of heart diseases.It has been discovered that the main strategy of slowing the progress of heart failure diseases is blocking the renin angiotensin aldosterone system（RAAS）.Angiotensin converting enzyme inhibitors（ACEI） and angiotensin receptor blockers（ARB） are the most commonly used RAAS-blocking drugs.In this paper,the assessment of chronic heart failure and the applications of ACEI and ARB in the treatment of chronic heart failure are reviewed.
作者 居海宁 卞金陵
机构地区 第二军医大学长海医院预防保健科 上海第七人民医院心血管内科
出处 《药学服务与研究》 CAS CSCD 2011年第5期377-381,共5页 Pharmaceutical Care and Research
关键词 心力衰竭 血管紧张素转换酶抑制剂 血管紧张素受体拮抗剂 综述 heart failure angiotensin converting enzyme inhibitors angiotensin receptor block ers review
分类号 R972 [医药卫生—药品]
  • 相关文献

参考文献26

  • 1Brady A J, Poole-Wilson P A. ESC CHF: guidelines for the aspirational and the practical[J]. Heart, 2006,92 (4): 4:37- 440.
  • 2Gilmour J. Caring for adults with chronic heart failure: rapid diagnosis and enhanced management[J]. Nurs Times, 2010, 106(45):16.
  • 3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量：3677
  • 4Braunwald E, Bristow M R. Congestive heart failure: fifty years of progress[J]. Circulation, 2000,102 ( 20 Suppl 4 ):14- 23.
  • 5Hunt S A, American College of Cardiology, American Heart Association Task Force on Practice Guidelines(Writing Com mittee to Update the 2001 Guidelines {or the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the aduh:a report of the American College of Cardi- ology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) [J]. J Am Coil Cardiol,2005,46(6):el -e82.
  • 6Kalra P R,Clague J R,Bolger A P,et al. Myocardial produc- tion of C-type natriuretic peptide in chronic heart failure[J]. Circulation, 2003,107(4):571-573.
  • 7Lainchbury J G, Troughton R W, Strangman K M, et al. N-terminal pro-B type natriuretic peptide-guided treatment for chronic heart failure : results from theBATTLESCARRED (NT proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial[J].J Am Coil Cardiol, 2009,55 ( 1 ) : 53-60.
  • 8Swedberg K, Held P, Kjekshus J, et al. Effects of the early administration of enalapril on mortality in patients with acute myocardial infraction. Results of the Cooperative New Scandi- navian Enalapril Survival Study Ⅱ(CONSENSUS Ⅱ)[J].N Engl Med J,1992,327(10) :678-684.
  • 9De Denus S,Tardif J C,White M,et ag. Quantification of the risk and predictors of hyperkalemia in patients with left ven- tricular dysfunction:a retrospective analysis of the Studies of Left Ventricular Dysfunction(SOLVD) trials[J]. Am Heart J,2006,152(4):705-712.
  • 10Garg R, Yusuf S. Overview of randomized trials of angiotensin converting enzyme inhibitors on mortality and morbidity in patient with heart failure. Collaborative Group on ACE Inhib itor Trials[J]. JAMA, 1995,273(18) : 1450-1456.

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量：90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3676

同被引文献68

引证文献8

药学服务与研究
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部